Terms: = Prostate cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Staging
5 results:
1. PET imaging of new target CDK19 in prostate cancer.
Dai D; Yu J; Huang T; Li Y; Wang Z; Yang S; Li S; Li Y; Gou W; Li D; Hou W; Fan S; Li Y; Zhao Y
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3452-3464. PubMed ID: 37278941
[TBL] [Abstract] [Full Text] [Related]
2. Head-to-Head Comparison of 68 Ga-p16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
3. Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre.
Haran C; McBean R; Parsons R; Wong D
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):495-499. PubMed ID: 30972933
[TBL] [Abstract] [Full Text] [Related]
4. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer.
Vargas HA; Donati OF; Wibmer A; Goldman DA; Mulhall JP; Sala E; Hricak H
J Sex Med; 2014 Oct; 11(10):2581-8. PubMed ID: 24754351
[TBL] [Abstract] [Full Text] [Related]
5. [Expressions of apoptosis-associated proteins in prostate carcinoma and their clinicopathological significance].
Zhang X; Li F; Jiang Y
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):193-6. PubMed ID: 12515134
[TBL] [Abstract] [Full Text] [Related]